Express News | Zhejiang Conba Pharmaceutical: The amikacin sulfate injection is expected to win the bid in the tenth batch of national pharmaceutical collective procurement.

BreakingsDec 13 21:35

Express News | The opening of the tenth batch of national Pharmaceutical centralized purchasing has prompted nearly 30 listed companies to announce their products are likely to be selected after the market close.

BreakingsDec 13 21:24

Zhejiang Conba Pharmaceutical (600572.SH): Participating in the tenth batch of national pharmaceutical centralized procurement intends to bid.

On December 13, Gelonghui reported that Zhejiang Conba Pharmaceutical (600572.SH) announced that on December 12, 2024, the company and its wholly-owned subsidiary Zhejiang Jinhua Conba Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinhua Conba") participated in the bidding of the tenth national centralized procurement organized by the National Joint Procurement Office (hereinafter referred to as the "Joint Procurement Office"). After the bidding and evaluation conducted by the Joint Procurement Office, the company's product Amikacin Sulfate Injection is expected to win the bid for this centralized procurement. The Amikacin Sulfate Injection has been selected for supply provinces based on market potential in each province.

Gelonghui FinanceDec 13 17:58

Zhejiang Conba Pharmaceutical seeks high-quality Assets as the key figure retires, ushering in a new era.

The ending and beginning of an era. A new era for Zhejiang Conba Pharmaceutical (600572.SH, hereinafter referred to as "the company") has arrived. In December, the company announced that its pharmaceutical product, Amikacin Sulfate Injection, has passed the consistency evaluation for generic drug quality and efficacy. The original research was conducted by a manufacturer in Japan, and in 2023, the domestic terminal market sales amounted to 0.458 billion yuan. The company has invested approximately 6.9 million yuan in R&D costs for conducting the consistency evaluation. Earlier, the company announced the election of Jiang Yi as the new Chairman, who previously worked under a platform of the Zhejiang State-owned Assets Supervision and Administration Commission, while the former Chairman, Hu Jiqiang, was appointed as Honorary Chairman.

China InvestorsDec 10 18:01

CONBA Pharma Gets Regulatory Nod to Make Changes to Amikacin Sulfate Injection

MT NewswiresDec 4 13:47

Express News | zhejiang conba pharmaceutical: Amikacin Sulfate Injection Passed Generic Drug Consistency Evaluation

BreakingsDec 3 16:40